RG
CLDX icon

Redmile Group’s Celldex Therapeutics CLDX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$6.98M Sell
343,026
-247,149
-42% -$5.03M 0.74% 29
2025
Q1
$10.7M Sell
590,175
-25,600
-4% -$465K 1.01% 23
2024
Q4
$15.6M Sell
615,775
-41,400
-6% -$1.05M 1.08% 27
2024
Q3
$22.3M Sell
657,175
-61,548
-9% -$2.09M 1.32% 28
2024
Q2
$26.6M Sell
718,723
-177,731
-20% -$6.58M 1.61% 25
2024
Q1
$37.6M Sell
896,454
-97,349
-10% -$4.09M 1.38% 28
2023
Q4
$39.4M Sell
993,803
-642,135
-39% -$25.5M 1.41% 22
2023
Q3
$45M Sell
1,635,938
-60,066
-4% -$1.65M 2.14% 10
2023
Q2
$57.5M Sell
1,696,004
-183,735
-10% -$6.23M 2.21% 9
2023
Q1
$67.6M Sell
1,879,739
-97,712
-5% -$3.52M 2.93% 9
2022
Q4
$88.1M Sell
1,977,451
-7,700
-0.4% -$343K 3.61% 8
2022
Q3
$55.8M Sell
1,985,151
-85,137
-4% -$2.39M 2.16% 14
2022
Q2
$55.8M Buy
2,070,288
+24,019
+1% +$648K 2.13% 13
2022
Q1
$69.7M Sell
2,046,269
-119,317
-6% -$4.06M 2.18% 12
2021
Q4
$83.7M Sell
2,165,586
-877,712
-29% -$33.9M 1.9% 15
2021
Q3
$164M Buy
3,043,298
+31,217
+1% +$1.69M 2.87% 10
2021
Q2
$101M Sell
3,012,081
-375,707
-11% -$12.6M 1.49% 20
2021
Q1
$69.8M Buy
3,387,788
+676,172
+25% +$13.9M 0.98% 39
2020
Q4
$47.5M Buy
2,711,616
+722,416
+36% +$12.7M 0.58% 47
2020
Q3
$29.5M Sell
1,989,200
-10,800
-0.5% -$160K 0.54% 47
2020
Q2
$26M Buy
+2,000,000
New +$26M 0.48% 55
2015
Q4
Sell
-1,954,019
Closed -$20.6M 59
2015
Q3
$20.6M Buy
1,954,019
+1,921,254
+5,864% +$20.2M 1.56% 21
2015
Q2
$826K Sell
32,765
-514,235
-94% -$13M 0.07% 54
2015
Q1
$15.2M Buy
547,000
+520,900
+1,996% +$14.5M 1.37% 32
2014
Q4
$476K Buy
+26,100
New +$476K 0.05% 47
2014
Q2
Sell
-863,947
Closed -$15.3M 51
2014
Q1
$15.3M Buy
863,947
+465,996
+117% +$8.23M 1.82% 25
2013
Q4
$9.63M Buy
+397,951
New +$9.63M 1.19% 35